FMC (NYSE:FMC) Issues Earnings Results

FMC (NYSE:FMC) released its quarterly earnings results on Tuesday. The basic materials company reported $1.79 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.65 by $0.14, Zacks reports. FMC had a net margin of 34.93% and a return on equity of 7.68%. FMC updated its Q1 2025 guidance to 0.050-0.150 EPS and its FY 2025 guidance to 3.260-3.700 EPS.

FMC Stock Down 1.7 %

Shares of NYSE:FMC opened at $54.00 on Wednesday. The company has a quick ratio of 1.09, a current ratio of 1.48 and a debt-to-equity ratio of 0.65. The stock has a market cap of $6.74 billion, a price-to-earnings ratio of 4.65, a PEG ratio of 1.20 and a beta of 0.84. The business’s 50 day moving average is $53.43 and its 200 day moving average is $58.85. FMC has a 12-month low of $47.71 and a 12-month high of $68.72.

FMC Announces Dividend

The business also recently declared a quarterly dividend, which was paid on Thursday, January 16th. Shareholders of record on Tuesday, December 31st were paid a dividend of $0.58 per share. The ex-dividend date was Tuesday, December 31st. This represents a $2.32 dividend on an annualized basis and a yield of 4.30%. FMC’s dividend payout ratio (DPR) is currently 19.97%.

Insider Transactions at FMC

In other FMC news, EVP Michael Finian Reilly sold 2,958 shares of the company’s stock in a transaction on Thursday, January 23rd. The stock was sold at an average price of $55.25, for a total value of $163,429.50. Following the completion of the transaction, the executive vice president now owns 25,468 shares in the company, valued at $1,407,107. This represents a 10.41 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, VP Jacqueline Scanlan sold 4,529 shares of FMC stock in a transaction dated Monday, November 11th. The stock was sold at an average price of $59.67, for a total transaction of $270,245.43. Following the completion of the sale, the vice president now directly owns 28,649 shares in the company, valued at approximately $1,709,485.83. This represents a 13.65 % decrease in their position. The disclosure for this sale can be found here. Insiders sold a total of 7,491 shares of company stock worth $433,898 in the last quarter. 0.81% of the stock is currently owned by corporate insiders.

Analysts Set New Price Targets

FMC has been the topic of a number of research analyst reports. Barclays raised shares of FMC from an “equal weight” rating to an “overweight” rating and set a $65.00 price target on the stock in a research report on Tuesday, January 21st. Citigroup upped their target price on FMC from $55.00 to $61.00 and gave the company a “neutral” rating in a research report on Wednesday, January 29th. Bank of America raised FMC from an “underperform” rating to a “neutral” rating and dropped their price target for the company from $63.00 to $61.00 in a research note on Tuesday, January 14th. Morgan Stanley reduced their price objective on shares of FMC from $70.00 to $46.00 and set an “equal weight” rating for the company in a research report on Wednesday. Finally, KeyCorp dropped their target price on shares of FMC from $79.00 to $69.00 and set an “overweight” rating on the stock in a research report on Thursday, January 2nd. Twelve investment analysts have rated the stock with a hold rating, three have given a buy rating and one has assigned a strong buy rating to the company’s stock. According to MarketBeat.com, FMC has a consensus rating of “Hold” and an average price target of $59.77.

FMC Company Profile

FMC Corporation, an agricultural sciences company, provides crop protection, plant health, and professional pest and turf management products. It develops, markets, and sells crop protection chemicals that includes insecticides, herbicides, and fungicides; and biologicals, crop nutrition, and seed treatment products, which are used in agriculture to enhance crop yield and quality by controlling a range of insects, weeds, and diseases, as well as in non-agricultural markets for pest control.